AlphaHelix Molecular Diagnostics AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 5.18 million compared to SEK 5.75 million a year ago. Revenue was SEK 5.37 million compared to SEK 5.8 million a year ago. Net loss was SEK 2.36 million compared to SEK 2.42 million a year ago. Basic loss per share from continuing operations was SEK 0.04 compared to SEK 0.04 a year ago.
For the six months, sales was SEK 13.58 million compared to SEK 18.86 million a year ago. Revenue was SEK 13.85 million compared to SEK 19.03 million a year ago. Net loss was SEK 2.92 million compared to SEK 0.997 million a year ago. Basic loss per share from continuing operations was SEK 0.05 compared to SEK 0.02 a year ago.